ロード中...
SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway
Recent advances in endocrine therapy have improved the prospects for estrogen receptor‐positive breast cancer. Tamoxifen is an effective drug for patients with estrogen receptor‐positive breast cancer, but the development of resistance is common. Therefore, discovering ways to enhance the sensitivit...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853819/ https://ncbi.nlm.nih.gov/pubmed/31573734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|